Contact
Please use this form to send email to PR contact of this press release:
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for FT 218 for the Treatment of Narcolepsy
TO:
Please use this form to send email to PR contact of this press release:
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for FT 218 for the Treatment of Narcolepsy
TO: